Literature DB >> 19838177

Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia.

Stefan A Grathwohl1, Roland E Kälin, Tristan Bolmont, Stefan Prokop, Georg Winkelmann, Stephan A Kaeser, Jörg Odenthal, Rebecca Radde, Therese Eldh, Sam Gandy, Adriano Aguzzi, Matthias Staufenbiel, Paul M Mathews, Hartwig Wolburg, Frank L Heppner, Mathias Jucker.   

Abstract

In Alzheimer's disease, microglia cluster around beta-amyloid deposits, suggesting that these cells are important for amyloid plaque formation, maintenance and/or clearance. We crossed two distinct APP transgenic mouse strains with CD11b-HSVTK mice, in which nearly complete ablation of microglia was achieved for up to 4 weeks after ganciclovir application. Neither amyloid plaque formation and maintenance nor amyloid-associated neuritic dystrophy depended on the presence of microglia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838177      PMCID: PMC4721582          DOI: 10.1038/nn.2432

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  15 in total

1.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

Authors:  M Stalder; A Phinney; A Probst; B Sommer; M Staufenbiel; M Jucker
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

Authors:  Dale Schenk
Journal:  Nat Rev Neurosci       Date:  2002-10       Impact factor: 34.870

3.  Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Authors:  Axel Nimmerjahn; Frank Kirchhoff; Fritjof Helmchen
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

4.  Deposition of amyloid in the liver of hamsters: an enzyme-histochemical and electron-microscopical study.

Authors:  E Gruys; H J Timmermans; A M van Ederen
Journal:  Lab Anim       Date:  1979-01       Impact factor: 2.471

5.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

Authors:  C Sturchler-Pierrat; D Abramowski; M Duke; K H Wiederhold; C Mistl; S Rothacher; B Ledermann; K Bürki; P Frey; P A Paganetti; C Waridel; M E Calhoun; M Jucker; A Probst; M Staufenbiel; B Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 6.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

Authors:  Tony Wyss-Coray
Journal:  Nat Med       Date:  2006-09       Impact factor: 53.440

7.  Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

Authors:  Rebecca Radde; Tristan Bolmont; Stephan A Kaeser; Janaky Coomaraswamy; Dennis Lindau; Lars Stoltze; Michael E Calhoun; Fabienne Jäggi; Hartwig Wolburg; Simon Gengler; Christian Haass; Bernardino Ghetti; Christian Czech; Christian Hölscher; Paul M Mathews; Mathias Jucker
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

8.  Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.

Authors:  Terrence Town; Yasmina Laouar; Christopher Pittenger; Takashi Mori; Christine A Szekely; Jun Tan; Ronald S Duman; Richard A Flavell
Journal:  Nat Med       Date:  2008-06-01       Impact factor: 53.440

Review 9.  Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.

Authors:  Joseph El Khoury; Andrew D Luster
Journal:  Trends Pharmacol Sci       Date:  2008-10-01       Impact factor: 14.819

10.  Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.

Authors:  Alain R Simard; Denis Soulet; Genevieve Gowing; Jean-Pierre Julien; Serge Rivest
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

View more
  191 in total

1.  Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.

Authors:  Srikant Rangaraju; Marla Gearing; Lee-Way Jin; Allan Levey
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice.

Authors:  Yuyan Zhu; Huayan Hou; Kavon Rezai-Zadeh; Brian Giunta; Amanda Ruscin; Carmelina Gemma; Jingji Jin; Natasa Dragicevic; Patrick Bradshaw; Suhail Rasool; Charles G Glabe; Jared Ehrhart; Paula Bickford; Takashi Mori; Demian Obregon; Terrence Town; Jun Tan
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

3.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

Review 4.  Microglial cell origin and phenotypes in health and disease.

Authors:  Kaoru Saijo; Christopher K Glass
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

Review 5.  The immunology of neurodegeneration.

Authors:  Eva Czirr; Tony Wyss-Coray
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 6.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration.

Authors:  Marco Prinz; Josef Priller; Sangram S Sisodia; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

7.  Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Future Neurol       Date:  2012-03-01

8.  Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice.

Authors:  Andrew W Kraft; Xiaoyan Hu; Hyejin Yoon; Ping Yan; Qingli Xiao; Yan Wang; So Chon Gil; Jennifer Brown; Ulrika Wilhelmsson; Jessica L Restivo; John R Cirrito; David M Holtzman; Jungsu Kim; Milos Pekny; Jin-Moo Lee
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 9.  Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.

Authors:  Alexandra Grubman; Katja M Kanninen; Tarja Malm
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

10.  Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses.

Authors:  Kirby M Donnelly; Olivia R DeLorenzo; Aprem DA Zaya; Gabrielle E Pisano; Wint M Thu; Liqun Luo; Ron R Kopito; Margaret M Panning Pearce
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.